After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, CRL falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Charles River Laboratories International Inc is $8.40B. A total of 1.15 million shares were traded on the day, compared to an average of 996.28K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, CRL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, FOSTER JAMES C bought 6,075 shares of CRL for 165.01 per share on Feb 20 ’25. After the transaction, the Chairman, President and CEO now owns 183,639 company shares. In a previous transaction on Feb 20 ’25, Girshick Birgit bought 1,514 shares at 164.63 per share. CRL shares that Corporate Executive VP & COO owns now total 55,058.
Among the insiders who sold shares, LaPlume Joseph W disposed of 4,400 shares on Feb 20 ’25 at a per-share price of $162.50. This resulted in the EVP, Corp Strategy & Develop holding 20,013 shares of CRL after the transaction. In another insider transaction, Joseph LaPlume bought 4,400 shares at $165.00 per share on Feb 20 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for CRL in the last 3 months, the mean price target is $175.81 with high estimates of $210.00 and low estimates of $130.00. In terms of 52-week highs and lows, CRL has a high of $275.00 and a low of $150.79.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $67.69, while its Total Shareholder’s Equity was $2.59B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 3.24.
